This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_STOMACH_NEUROENDOCRINE_EXALLC for full statistics.
Neuroendocrine tumor and carcinoma of stomach
C3_STOMACH_NEUROENDOCRINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of stomach
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 84 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 62.11 | 59.36 | 65.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 149
- Matched controls
- 1491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K29.4
ICD-10 Finland
Chronic atrophic gastritis
132.6
85.0
86
15
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
+∞
78.1
68
*
B03BA03
ATC
hydroxocobalamin; parenteral
49.2
77.1
97
54
107
Kela drug reimbursment
Pernicious anaemia
94.3
63.9
68
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
18.3
51.3
124
317
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
69.8
51.0
57
13
B81
ICPC
Anaemia vit B12/folate deficiency
33.9
49.0
65
33
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
+∞
46.3
42
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
135.2
38.9
40
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
+∞
26.9
25
*
UJD02
NOMESCO Finland
Gastroscopy
9.1
13.2
28
37
E34.0
ICD-10 Finland
Carcinoid syndrome
55.1
13.1
15
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
55.1
13.1
15
*
A50
ICPC
General and Unspecified, Medication/prescr/renewal
10.9
11.2
21
22
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
35.3
10.5
13
*
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
106.4
9.5
10
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
23.5
9.5
13
6
8240/3-C16.0
ICD-O-3
Neuroendocrine tumor, NOS, of cardia, NOS
+∞
9.5
9
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.2
8.0
25
56
UJF32
NOMESCO Finland
Coloscopy
2.8
7.5
59
280
S50
ICPC
Skin, Medication/prescr/renewal
84.0
7.5
8
*
130
Kela drug reimbursment
Malignant tumour
4.3
6.9
25
66
H01CB02
ATC
octreotide; parenteral
42.0
6.8
8
*
A55
ICPC
General and Unspecified, Local injection/infiltration
23.8
6.8
9
*
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
28.0
6.3
8
*
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
+∞
6.3
6
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
6.3
6
*
8249/3-C16.2
ICD-O-3
Neuroendocrine tumor, grade 2 of body of stomach
+∞
6.3
6
*
8249/3-C16.9
ICD-O-3
Neuroendocrine tumor, grade 2 of stomach, NOS
+∞
6.3
6
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.9
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
75
314
3.61
14.28
3.2
2.0
3.5
3.4
mg/l
0.09
67
270
96
548
2.88
9.70
3.0
1.9
81.8
97.1
pmol/l
1.96
60
267
12
14
9.19
9.47
1.7
1.4
11.8
15.7
ug/l
1.64
12
14
88
501
2.68
8.62
4.5
2.4
86.7
139.0
ug/l
1.07
81
451
95
576
2.60
7.97
5.8
4.1
34.4
34.9
g/l
0.38
87
538
47
208
2.78
7.40
2.7
2.0
12.3
12.8
umol/l
0.08
42
190
59
307
2.46
6.59
2.5
1.8
650.0
466.0
pmol/l
0.91
48
251
42
186
2.71
6.54
2.5
2.1
19.3
21.7
%
0.23
36
163
59
324
2.30
5.71
1.7
1.5
26.2
21.6
nmol/l
1.09
53
261
50
272
2.22
4.84
2.1
1.7
1065.0
1225.7
nmol/l
0.71
37
205
102
736
2.06
4.58
7.4
6.2
11.1
11.7
umol/l
0.35
96
693
96
680
2.03
4.51
6.4
6.2
1.2
1.2
mmol/l
0.18
80
558
100
733
1.97
4.10
10.2
10.0
4.6
4.2
e9/l
0.73
87
646
88
620
1.93
4.04
6.0
5.8
1.2
1.2
mmol/l
0.22
81
551
32
156
2.31
3.96
2.9
4.5
13.8
12.8
ug/l
0.04
26
126
76
527
1.84
3.52
2.7
2.2
80.0
78.0
nmol/l
0.19
69
456
81
589
1.76
3.09
3.8
3.8
—
—
—
0
0
48
305
1.82
2.85
2.5
2.2
—
—
—
0
0
64
445
1.73
2.79
3.7
3.3
2.3
2.3
mmol/l
0.14
54
381
52
345
1.75
2.65
2.1
3.0
334.0
9334.2
umol/l
2.26
41
287
36
216
1.86
2.54
1.2
1.3
15.0
41.1
iu/ml
—
10
77
38
246
1.71
2.07
5.6
3.3
120.8
136.6
ng/l
0.08
31
203
112
946
1.61
2.02
5.8
3.9
15.3
15.0
pmol/l
0.75
102
838
19
99
2.04
2.00
2.8
3.2
89.8
76.5
ng/l
0.48
19
89
38
253
1.66
1.86
3.8
3.0
2.5
2.5
mmol/l
0.13
30
222
8
29
2.85
1.82
1.0
1.3
—
—
—
0
0
41
281
1.62
1.79
1.4
1.8
1.5
1.6
mg/l
0.04
30
225
98
817
1.51
1.76
3.9
3.0
68.2
50.1
u/l
0.75
90
755
7
25
2.88
1.67
1.0
1.5
—
—
—
0
0
5
14
3.65
1.63
1.2
1.1
—
—
—
0
0
38
265
1.57
1.54
1.4
1.2
0.6
1.7
u/ml
—
8
87
79
647
1.44
1.45
4.7
4.3
0.0
0.0
estimate
0.00
14
123
78
639
1.43
1.42
5.5
5.8
0.0
0.0
estimate
0.00
15
134
9
43
2.16
1.32
1.2
2.0
—
—
—
0
0
77
638
1.40
1.28
4.6
4.3
0.0
0.0
estimate
0.00
14
132
16
93
1.80
1.26
1.9
1.5
—
—
—
0
0
57
456
1.39
1.14
3.2
3.4
1583.7
1415.8
ng/l
0.15
48
379
15
89
1.76
1.12
1.1
1.3
—
—
—
0
0
7
31
2.31
1.12
2.0
1.4
—
—
—
0
0
5
21
2.42
1.10
1.6
3.3
—
23.4
—
0
5
69
573
1.36
1.09
3.7
4.2
194.0
41.4
ng/l
0.46
52
415
7
37
1.93
0.95
1.9
1.4
—
0.1
—
0
10
6
28
2.19
0.92
1.3
1.4
—
—
—
0
0
28
206
1.44
0.89
1.4
1.3
1.2
9.5
u/ml
—
8
79
17
112
1.58
0.89
2.5
3.2
4.3
4.2
kpa
0.07
17
107
25
180
1.46
0.89
18.1
21.1
1.4
1.4
inr
—
7
21
8
43
1.90
0.89
3.8
2.7
—
—
—
0
0
6
31
1.97
0.85
1.0
1.1
—
—
—
0
0
8
47
1.74
0.82
1.3
4.4
—
4.3
—
0
5
20
140
1.49
0.82
2.1
1.7
—
—
—
0
0
12
74
1.67
0.80
2.6
1.6
—
—
—
0
0
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
0
27
0.00
0.78
0.0
2.0
—
—
—
0
0
28
214
1.37
0.73
2.0
1.9
—
—
—
0
0
20
144
1.44
0.72
2.1
1.8
—
—
—
0
0
28
216
1.36
0.69
1.7
1.9
29.1
29.4
s
0.10
28
210
57
487
1.26
0.69
4.3
3.1
—
—
—
0
0
5
28
1.81
0.66
1.6
1.2
—
—
—
0
0
10
63
1.63
0.63
1.1
1.9
—
—
—
0
0
124
1165
1.29
0.63
6.9
4.7
1.8
2.0
mu/l
0.46
116
1032
8
51
1.60
0.61
1.8
1.8
—
—
—
0
0
117
1239
0.79
0.59
5.4
4.7
1.4
1.5
mmol/l
1.04
106
1121
8
53
1.54
0.59
1.0
1.0
—
—
—
0
0
113
1201
0.80
0.59
4.7
4.3
1.3
1.3
mmol/l
0.11
100
1082
8
54
1.51
0.58
1.8
2.1
—
—
—
0
0
5
88
0.55
0.58
2.0
1.9
—
—
—
0
0
8
55
1.48
0.57
1.3
1.3
—
—
—
0
0
6
37
1.65
0.56
1.7
1.5
—
—
—
0
0
6
40
1.52
0.52
1.0
1.2
—
—
—
0
0
57
502
1.21
0.51
4.7
4.5
—
—
—
0
0
119
1250
0.81
0.49
5.4
4.8
4.2
4.6
mmol/l
3.36
108
1137
122
1277
0.81
0.47
6.1
5.3
2.4
2.7
mmol/l
3.12
111
1155
132
1263
1.26
0.47
22.6
15.4
27.0
23.4
mg/l
0.61
118
1007
41
352
1.22
0.47
5.8
4.5
0.0
0.0
estimate
0.00
14
132
10
69
1.48
0.45
1.4
2.9
1.1
1.3
%
—
10
69
5
32
1.58
0.42
1.0
2.6
169.6
215.0
%
—
5
32
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
20
160
1.29
0.41
4.9
6.8
-0.3
1.0
mmol/l
0.73
13
127
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
20
161
1.28
0.39
9.3
8.6
—
—
—
0
0
0
19
0.00
0.39
0.0
3.8
—
—
—
0
0
19
152
1.28
0.39
3.4
3.8
—
—
—
0
0
71
651
1.16
0.38
3.1
2.6
—
—
—
0
0
11
81
1.38
0.37
4.6
6.5
25.0
24.7
mmol/l
0.10
11
81
6
43
1.41
0.35
1.8
1.1
—
—
—
0
0
26
222
1.20
0.32
5.2
3.0
2.3
2.2
e6/l
0.02
14
126
43
392
1.13
0.24
4.0
3.1
2.5
0.5
e6/l
0.92
32
300
136
1328
1.16
0.23
26.3
17.7
139.2
139.8
mmol/l
1.78
136
1288
5
41
1.23
0.22
1.0
1.2
—
—
—
0
0
15
126
1.21
0.22
2.3
4.0
1.2
1.2
mmol/l
0.55
15
110
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
463.8
—
0
6
0
11
0.00
0.21
0.0
1.1
—
41.8
—
0
6
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
180.5
—
0
12
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
4.2
—
119.2
—
0
14
41
378
1.11
0.19
3.4
4.5
20.1
20.6
%
0.09
16
189
124
1208
1.12
0.19
9.1
6.3
43.9
40.8
mmol/mol
2.04
117
1114
136
1333
1.14
0.18
26.4
17.7
3.9
4.0
mmol/l
2.08
136
1292
136
1385
0.88
0.18
35.5
22.6
128.9
134.6
g/l
4.11
136
1359
136
1335
1.12
0.16
27.1
18.4
79.5
79.8
umol/l
0.03
136
1335
9
80
1.13
0.15
5.2
9.1
24.1
24.4
mmol/l
—
9
72
26
237
1.12
0.15
4.5
2.7
1.2
1.1
e6/l
0.04
14
139
127
1248
1.09
0.12
6.5
4.9
6.5
6.1
mmol/l
2.01
121
1129
111
1087
1.07
0.11
24.4
16.0
37.6
39.6
%
0.92
74
737
5
45
1.11
0.10
1.2
2.2
0.0
0.0
g/l
—
5
45
46
479
0.94
0.08
4.5
5.1
6.4
3.1
ug/l
0.42
40
419
6
58
1.04
0.08
2.0
1.4
—
—
—
0
0
5
63
0.79
0.08
2.4
3.1
4.4
4.3
pmol/l
—
5
55
31
294
1.07
0.08
2.3
3.2
0.9
0.8
ug/l
0.14
21
192
18
181
0.99
0.00
4.7
4.6
38.6
32.0
%
1.63
11
112
122
1218
1.01
0.00
23.6
14.7
77.9
75.9
ml/min/173m2
0.48
108
1006
16
162
0.99
0.00
1.6
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
5
54
0.92
0.00
1.2
2.0
36.9
37.5
g/l
—
5
49
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
11.0
—
0
7
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
5
52
0.96
0.00
2.2
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
570.2
—
0
6
0
5
0.00
0.00
0.0
1.4
—
18.4
—
0
5
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
16
160
1.00
0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
11.9
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_STOMACH_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).